Buy & Sell FedEx Corporation (FDX) – FedEx Corporation Price Today
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...
Small-cap ETFs may rebound as investors overlook them amid mega-cap tech focus, creating potential buying opportunities.
Small-cap stocks are starting to outperform again, but ETF investors remain focused on mega-cap technology and AI stocks, leading to small-cap ETFs holding only about 4% of ETF assets down from 10%. Despite $25 billion outflows from small-cap mutual ...
Supreme Court rejects Eli Lilly's appeal, upholding $194M Medicaid fraud judgment.
The U.S. Supreme Court declined to hear Eli Lilly's appeal, leaving a $194 million whistleblower judgment intact. The case involved allegations that Eli Lilly underreported drug pricing to reduce Medicaid rebate payments by about $61 million. The rul...
Myasthenia gravis market to exceed $16B by 2036 driven by rising diagnoses and new targeted biologics.
The myasthenia gravis market, valued at around $6 billion in 2025, is projected to grow at a 9.1% CAGR to surpass $16 billion by 2036. Growth is fueled by increasing diagnosed cases, especially among older populations, and a surge in innovative targe...
Cullinan Therapeutics to present initial clinical data for CLN-978 in RA and SLE at EULAR 2026
Cullinan Therapeutics announced it will present initial Phase 1 clinical data for CLN-978, a novel CD19xCD3 T cell engager, at the EULAR 2026 Congress. The data comes from ongoing studies in treatment-refractory rheumatoid arthritis (RA) and systemic...
McDonald's growth driven by real estate assets and AI, targeting 50,000 restaurants by 2027 with strong cash flow.
McDonald's operates a robust, asset-heavy business model with 60% of its operating income coming from real estate, owning 80% of its buildings and about 50% of the land across 45,000+ locations worldwide. This model supports high margins and steady c...
TLX101-Tx trial for first-line glioblastoma completes enrolment with no severe toxicities.
Telix Pharmaceuticals announced that the IPAX-2 Phase 1 trial of TLX101-Tx for newly diagnosed glioblastoma has completed patient enrolment with no dose-limiting toxicities observed, even at the highest dose tested. This trial evaluates TLX101-Tx com...
Antalpha expands into AI infrastructure with new intelligent routing systems and AI tools.
Antalpha announced a strategic expansion into AI infrastructure, introducing its proprietary Model Context Protocol (MCP) framework to support intelligent routing and coordination across data environments. The company also launched "Nina," an early-s...